Novavax to deliver 350 mln COVID-19 vaccine doses to COVAX scheme
The Peninsula
Novavax Inc said on Thursday it has signed an agreement with the GAVI vaccine alliance to manufacture and distribute 350 million doses of its COVID-19 vaccine candidate to countries participating in the COVAX facility.
The COVAX facility, a global initiative aimed at equitable access to COVID-19 vaccines for poorer countries, is co-led by GAVI, the World Health Organization and the Coalition for Epidemic Preparedness Innovations. The company said India's Serum Institute will manufacture and deliver the balance of the 1.1 billion doses of its vaccine to be delivered to the COVAX vaccine scheme, under a separate agreement.More Related News